|
Index of reports
> Hospitalization (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nystatin hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Nystatin side effects in male
Reported by a lawyer from United States on 2012-07-12
Patient: male
Reactions: Cleft LIP and Palate, Cerebral Palsy, Torticollis, Craniosynostosis, Lacrimal Disorder, Developmental Delay, Plagiocephaly, Feeding Disorder, Hydrocele, Duane's Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Oxycodone / Acetaminophen
Indication: Foetal Exposure During Pregnancy
Nystatin
Indication: Foetal Exposure During Pregnancy
Vicodin
Indication: Foetal Exposure During Pregnancy
Acetaminophen
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
Oxycontin
Indication: Foetal Exposure During Pregnancy
Ovcon-35
Indication: Foetal Exposure During Pregnancy
Ultram
Indication: Foetal Exposure During Pregnancy
Soma
Indication: Foetal Exposure During Pregnancy
Feldene
Indication: Foetal Exposure During Pregnancy
Crestor
Indication: Foetal Exposure During Pregnancy
Effexor
Indication: Foetal Exposure During Pregnancy
Selective Serotonin Reuptake Inhibitor
Indication: Foetal Exposure During Pregnancy
Other drugs received by patient: Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Folic Acid; Fish OIL
Possible Nystatin side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-15
Patient: male
Reactions: Cerebral Palsy, Cleft LIP and Palate, Maternal Drugs Affecting Foetus, Ear Infection, Torticollis, Craniosynostosis, Lacrimal Disorder, Developmental Delay, Plagiocephaly, Dacryostenosis Congenital, Hypermetropia, Feeding Disorder, Hydrocele, Duane's Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Oxycontin
Indication: Foetal Exposure During Pregnancy
Effexor
Indication: Foetal Exposure During Pregnancy
Vicodin
Indication: Foetal Exposure During Pregnancy
Acetaminophen
Indication: Foetal Exposure During Pregnancy
Crestor
Indication: Foetal Exposure During Pregnancy
Ovcon-35
Indication: Foetal Exposure During Pregnancy
Nystatin
Indication: Foetal Exposure During Pregnancy
Selective Serotonin Reuptake Inhibitor
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
Soma
Indication: Foetal Exposure During Pregnancy
Feldene
Indication: Foetal Exposure During Pregnancy
Acetaminophen
Ultram
Indication: Foetal Exposure During Pregnancy
Oxycodone / Acetaminophen
Indication: Foetal Exposure During Pregnancy
Other drugs received by patient: Leucovorin Calcium; Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Fish OIL
Possible Nystatin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: male
Reactions: Cleft LIP and Palate, Torticollis, Craniosynostosis, Lacrimal Disorder, Developmental Delay, Feeding Disorder, Duane's Syndrome, Hydrocele
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ovcon-35
Indication: Foetal Exposure During Pregnancy
Soma
Indication: Foetal Exposure During Pregnancy
Vicodin
Indication: Foetal Exposure During Pregnancy
Effexor
Indication: Foetal Exposure During Pregnancy
Acetaminophen
Feldene
Indication: Foetal Exposure During Pregnancy
Selective Serotonin Reuptake Inhibitor
Indication: Foetal Exposure During Pregnancy
Ultram
Indication: Foetal Exposure During Pregnancy
Oxycontin
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
Oxycodone / Acetaminophen
Indication: Foetal Exposure During Pregnancy
Crestor
Indication: Foetal Exposure During Pregnancy
Nystatin
Indication: Foetal Exposure During Pregnancy
Acetaminophen
Indication: Foetal Exposure During Pregnancy
Other drugs received by patient: Leucovorin Calcium; Fish OIL; Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP
Possible Nystatin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: male
Reactions: Cleft LIP and Palate, Craniosynostosis, Developmental Delay, Torticollis, Feeding Disorder, Hydrocele, Duane's Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Indication: Foetal Exposure During Pregnancy
Crestor
Indication: Foetal Exposure During Pregnancy
Feldene
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
Oxycodone / Acetaminophen
Indication: Foetal Exposure During Pregnancy
Acetaminophen
Selective Serotonin Reuptake Inhibitor
Indication: Foetal Exposure During Pregnancy
Ovcon-35
Indication: Foetal Exposure During Pregnancy
Oxycontin
Indication: Foetal Exposure During Pregnancy
Vicodin
Indication: Foetal Exposure During Pregnancy
Ultram
Indication: Foetal Exposure During Pregnancy
Soma
Indication: Foetal Exposure During Pregnancy
Nystatin
Indication: Foetal Exposure During Pregnancy
Effexor
Indication: Foetal Exposure During Pregnancy
Other drugs received by patient: Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Folic Acid; Fish OIL
Possible Nystatin side effects in 76 year old female
Reported by a individual with unspecified qualification from United States on 2012-01-27
Patient: 76 year old female, weighing 55.3 kg (121.7 pounds)
Reactions: Tinnitus, Head Discomfort, Hypersensitivity, Pain in Extremity, Nasal Discomfort, Drug Ineffective, Upper-Airway Cough Syndrome, Oropharyngeal Pain, Dyspepsia, DRY Throat, DRY Mouth, Musculoskeletal Stiffness, DRY Eye, Transient Ischaemic Attack
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Unspecified Medication
Start date: 2011-01-01
End date: 2011-01-01
Claritin-D
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Nystatin
Dosage: one teaspoon every six hours
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Unspecified Allergy Tablet
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Centrum Silver Ultra Women's
Dosage: daily
Administration route: Oral
Indication: Vitamin Supplementation
Start date: 2011-04-01
End date: 2011-11-01
Claritin
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Unspecified Nose Spray
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Prilosec
Dosage: two times a day
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Hydrogen Peroxide Solution
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Other drugs received by patient: Lunesta
Possible Nystatin side effects in 76 year old female
Reported by a individual with unspecified qualification from United States on 2012-01-03
Patient: 76 year old female, weighing 55.3 kg (121.7 pounds)
Reactions: Head Discomfort, Tinnitus, Hypersensitivity, Drug Ineffective, Pain in Extremity, Oropharyngeal Pain, Dyspepsia, DRY Throat, DRY Mouth, Musculoskeletal Stiffness, Transient Ischaemic Attack
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Centrum Silver Ultra Women's
Dosage: daily
Administration route: Oral
Indication: Medical Diet
Start date: 2011-04-01
End date: 2011-11-01
Hydrogen Peroxide Solution
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Nystatin
Dosage: one teaspoon every six hours
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Unspecified Nose Spray
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Unspecified Medication
Start date: 2011-01-01
End date: 2011-01-01
Claritin
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Prilosec
Dosage: two times a day
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Unspecified Allergy Tablet
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Claritin-D
Administration route: Oral
Indication: Oropharyngeal Pain
Start date: 2011-01-01
Other drugs received by patient: Lunesta
Possible Nystatin side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-18
Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Hyperpyrexia, Bronchopneumonia, Wheezing, Pyrexia, Multi-Organ Failure, Oral Candidiasis, Pulmonary Congestion, Cough, Renal Failure Acute, Oxygen Saturation Decreased, Dyspnoea, Metabolic Acidosis, Maternal Exposure During Pregnancy, Respiratory Distress, Cardiogenic Shock, Agranulocytosis, Fungal Infection, Oliguria, Systemic Inflammatory Response Syndrome, Neutropenia, Fusarium Infection, Septic Shock, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Nitrofurantoin
Indication: Infection Prophylaxis
Ganciclovir
Indication: Fusarium Infection
Nystatin
Administration route: Oral
Indication: Fusarium Infection
Amphotericin B
Ceftriaxone
Nystatin
Administration route: Oral
Metamizole Sodium
Indication: Tracheobronchitis
Ceftriaxone
Indication: Pyelonephritis
Ceftriaxone
Indication: Tracheobronchitis
Ceftriaxone
Clarithromycin
Indication: Fusarium Infection
Imipenem
Indication: Tracheobronchitis
Imipenem
Propranolol HCL
Indication: Mitral Valve Stenosis
Furosemide
Indication: Pulmonary Congestion
Nystatin
Administration route: Oral
Indication: Tracheobronchitis
Imipenem
Indication: Fusarium Infection
Ganciclovir
Vancomycin
Indication: Tracheobronchitis
Clarithromycin
Indication: Tracheobronchitis
Vancomycin
Clarithromycin
Ganciclovir
Indication: Tracheobronchitis
Vancomycin
Indication: Fusarium Infection
Amphotericin B
Indication: Tracheobronchitis
Amphotericin B
Indication: Fusarium Infection
Other drugs received by patient: Oxytocin; Dobutamine HCL; Vitamin TAB; Sodium Chloride; Nitric Oxide
Possible Nystatin side effects in female
Reported by a individual with unspecified qualification from United States on 2011-11-09
Patient: female, weighing 86.0 kg (189.2 pounds)
Reactions: Stomatitis, Oesophagitis, Hypomagnesaemia, Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Paclitaxel
Dosage: over 1 hour on day 1 of weeks 1-12 (cycle: 19 weeks)
Indication: Breast Cancer
Cyclophosphamide
Dosage: over 5-30 min on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose:2334 mg
Indication: Breast Cancer
Nystatin
Indication: Product Used FOR Unknown Indication
Doxorubicin HCL
Dosage: over 5-10 mins on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose: 234 mg
Indication: Breast Cancer
Avastin
Dosage: over 30-90 min on day 1 of weeks 1, 3, 5, 7, 9, 11, 13, 15 and 17 (cycle: 19 weeks); last date of ad
Indication: Breast Cancer
Docusate Sodium
Indication: Product Used FOR Unknown Indication
Hydromorphone HCL
Indication: Product Used FOR Unknown Indication
Carboplatin
Dosage: auc 6 over 30 min on day 1 of weeks 1, 4, 7 and 10 .cycle: 19 weeks, total dose:3600 mg
Indication: Breast Cancer
Prochlorperazine
Indication: Product Used FOR Unknown Indication
Lorazepam
Indication: Product Used FOR Unknown Indication
Mouthwash NOS
Indication: Product Used FOR Unknown Indication
Omeprazole
Indication: Product Used FOR Unknown Indication
Possible Nystatin side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-04
Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Pulmonary Hypertension, Hypovolaemic Shock, Agitation, Oligohydramnios, Bronchopneumonia, Pulmonary Embolism, Tricuspid Valve Incompetence, Cardiomegaly, Caesarean Section, Oral Candidiasis, Bronchopulmonary Aspergillosis, Pulmonary Necrosis, Metabolic Acidosis, Cytomegalovirus Test Positive, Parvovirus B19 Test Positive, Hypotension, Kidney Fibrosis, Bone Marrow Oedema, Maternal Exposure During Pregnancy, Respiratory Distress, Convulsion, Depressed Level of Consciousness, Premature Delivery, Aortic Valve Incompetence, Septic Shock, Multi-Organ Failure, Postpartum Sepsis, Pulmonary Congestion, Bone Marrow Failure, Renal Failure Acute, Tracheobronchitis, Renal Tubular Atrophy, Febrile Neutropenia, Cardiogenic Shock, Agranulocytosis, Cardiac Arrest, Mitral Valve Stenosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Vancomycin HCL
Propranolol
Dosage: 40 mg, 2x/day
Dipyrone TAB
Nystatin
Ceftriaxone Sodium
Dosage: 2 g, 1x/day
Indication: Pyelonephritis
Ganciclovir
Clarithromycin
Furosemide
Dosage: 40 mg, 2x/day
Macrodantin
Indication: Prophylaxis
Imipenem
Ceftriaxone Sodium
Indication: Tracheobronchitis
Other drugs received by patient: Nitric Oxide; Oxytocin
Possible Nystatin side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-02
Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Agitation, Pulmonary Hypertension, Oligohydramnios, Bronchopneumonia, Lung Infection, Rales, Pulmonary Embolism, Tricuspid Valve Incompetence, Pyrexia, Cardiomegaly, Caesarean Section, Oral Candidiasis, Cardiac Failure Congestive, Cough, Bronchopulmonary Aspergillosis, Pulmonary Necrosis, Metabolic Acidosis, Parvovirus B19 Test Positive, Cytomegalovirus Test Positive, Maternal Exposure During Pregnancy, Kidney Fibrosis, Bone Marrow Oedema, General Physical Health Deterioration, Respiratory Distress, Convulsion, NO Therapeutic Response, Depressed Level of Consciousness, Systemic Inflammatory Response Syndrome, Neutropenia, Premature Delivery, Aortic Valve Incompetence, Septic Shock, Wheezing, Pallor, Multi-Organ Failure, Postpartum Sepsis, Pulmonary Congestion, Bone Marrow Failure, Renal Failure Acute, Oxygen Saturation Decreased, Tracheobronchitis, Renal Tubular Atrophy, Odynophagia, Cardiogenic Shock, Agranulocytosis, Intestinal Dilatation, Heart Rate Increased, Oliguria, Blood Pressure Decreased, Cardiac Arrest, Leukocytosis, Leukopenia, Localised Intraabdominal Fluid Collection, Mitral Valve Stenosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Propranolol
Dosage: 80 mg (40 mg, 2 in 1 d)
Indication: Product Used FOR Unknown Indication
Furosemide
Dosage: 80 mg (40 mg, 2 in 1 d)
Indication: Product Used FOR Unknown Indication
Macrodantin
Indication: Prophylaxis
Dipyrone INJ
Indication: Product Used FOR Unknown Indication
Nystatin
Indication: Product Used FOR Unknown Indication
Clarithromycin
Indication: Product Used FOR Unknown Indication
Vancomycin
Indication: Product Used FOR Unknown Indication
Ceftriaxone
Dosage: intramuscular, (2 gm, 1 d), intramuscular
Indication: Tracheobronchitis
Ceftriaxone
Dosage: intramuscular, (2 gm, 1 d), intramuscular
Indication: Pyelonephritis
Imipenem (Imipenem)
Indication: Product Used FOR Unknown Indication
Ganciclovir
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Oxytocin; Nitric Oxyde (Nitric Oxyde)
Possible Nystatin side effects in female
Reported by a individual with unspecified qualification from United States on 2011-10-31
Patient: female, weighing 86.0 kg (189.2 pounds)
Reactions: Stomatitis, Oesophagitis, Hypomagnesaemia, Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: over 30-90 min on day 1 of weeks 1, 3, 5, 7, 9, 11, 13, 15 and 17 (cycle: 19 weeks); last date of ad
Indication: Breast Cancer
Paclitaxel
Dosage: over 1 hour on day 1 of weeks 1-12 (cycle: 19 weeks)
Indication: Breast Cancer
Carboplatin
Dosage: auc 6 over 30 min on day 1 of weeks 1, 4, 7 and 10 .cycle: 19 weeks, total dose:3600 mg
Indication: Breast Cancer
Cyclophosphamide
Dosage: over 5-30 min on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose:2334 mg
Indication: Breast Cancer
Hydromorphone Hydrochloride
Indication: Product Used FOR Unknown Indication
Omeprazole
Indication: Product Used FOR Unknown Indication
Lorazepam
Indication: Product Used FOR Unknown Indication
Mouthwash NOS
Indication: Product Used FOR Unknown Indication
Nystatin
Indication: Product Used FOR Unknown Indication
Docusate Sodium
Indication: Product Used FOR Unknown Indication
Prochlorperazine
Indication: Product Used FOR Unknown Indication
Doxorubicin HCL
Dosage: over 5-10 mins on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose: 234 mg
Indication: Breast Cancer
|
